Changes in, and factors associated with family functioning: results of four cross-sectional household surveys from 2011 to 2017 in Hong Kong

Autor: Camilla Kin Ming Lo, Qiqi Chen, Mengtong Chen, Ko Ling Chan, Patrick Ip

Publikováno v: BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)

Abstract Background Previous research has well-documented that family functioning is an important predictor of individuals’ physical and mental health. However, relatively little research has explored family functioning at the family and population

Externí odkaz: https://doaj.org/article/ac59141761d849ca97840cb7369b54f2

NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models

Autor: Chunxiao Xu, Bo Marelli, Jin Qi, Guozhong Qin, Huakui Yu, Hong Wang, Molly H. Jenkins, Kin-Ming Lo, Yan Lan

Publikováno v: Translational Oncology, Vol 16, Iss , Pp 101322- (2022)

Combinatorial immunotherapy approaches are emerging as viable cancer therapeutic strategies for improving patient responses and outcomes. This study investigated whether two such immunotherapies, with complementary mechanisms of action, could enhance

Externí odkaz: https://doaj.org/article/0c7104ef8b634873aca80c7a07f5a5fd

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

Autor: Sneha Berry, Nicolas Giraldo, Peter Nguyen, Benjamin Green, Haiying Xu, Aleksandra Ogurtsova, Abha Soni, Farah Succaria, Daphne Wang, Charles Roberts, Julie Stein, Elizabeth Engle, Drew Pardoll, Robert Anders, Tricia Cottrell, Janis M. Taube, Ben Tran, Mark Voskoboynik, James Kuo, Yung-Lue Bang, Hyun-Cheo Chung, Myung-Ju Ahn, Sang-We Kim, Ayesh Perera, Daniel Freeman, Ikbel Achour, Raffaella Faggioni, Feng Xiao, Charles Ferte, Charlotte Lemech, Funda Meric-Bernstam, Theresa Werner, Stephen Hodi, Wells Messersmith, Nancy Lewis, Craig Talluto, Mirek Dostalek, Aiyang Tao, Sarah McWhirter, Damian Trujillo, Jason Luke, Chunxiao Xu, BoMarelli, Jin Qi, Guozhong Qin, Huakui Yu, Molly Jenkins, Kin-Ming Lo, Joern-Peter Halle, Yan Lan, Matthew Taylor, Nicholas Vogelzang, Allen Cohn, Daniel Stepan, Robert Shumaker, Corina Dutcus, Matthew Guo, Emmett Schmidt, Drew Rasco, Marcia Brose, Christopher Di Simone, Sharad Jain, Donald Richards, Carlos Encarnacion, James Mier, Jeongshin An, Yeun-yeoul Yang, Won-Hee Lee, Jinho Yang, Jong-kyu Kim, Hyun Goo Kim, Se Hyun Paek, Jun Woo Lee, Joohyun Woo, Jong Bin Kim, Hyungju Kwon, Woosung Lim, Nam Sun Paik, Yoon-Keun Kim, Byung-In Moon, Filip Janku, David Tan, Juan Martin-Liberal, Shunji Takahashi, Ravit Geva, Ayca Gucalp, Xueying Chen, Kulandayan Subramanian, Jennifer Mataraza, Jennifer Wheler, Philippe Bedard

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)

After publication of this supplement [1, 2], it was brought to our attention that due to an error authors were missing in the following abstracts. This has now been included in this correction.

Externí odkaz: https://doaj.org/article/5e0fdcdf298e4148a8ad792b96d6446a

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer

Autor: Sarah K. Wootton, Simone ten Kortenaar, Jack Lawler, Jim Petrik, Madison Pereira, Lisa A. Santry, Byram W. Bridle, Kathy Matuszewska, Duncan Petrik, Kin-Ming Lo

Publikováno v: Gynecologic Oncology. 164:154-169

Objectives Tumor vasculature is structurally abnormal, with anatomical deformities, reduced pericyte coverage and low tissue perfusion. As a result of this vascular dysfunction, tumors are often hypoxic, which is associated with an aggressive tumor p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072b70f1ff700a9681583a1bdd7b7eb5
https://doi.org/10.1016/j.ygyno.2021.11.006

Data from Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Autor: Yan Lan, Laszlo Radvanyi, Jessie M. English, Kin-Ming Lo, Robert Tighe, Huakui Yu, Hong Wang, Jin Qi, Guozhong Qin, Bo Marelli, Giorgio Kradjian, Wilson Guzman, Vivian M. Hernández, P. Alexander Rolfe, Yanping Zhang, Chunxiao Xu

Purpose: To determine whether combination therapy with NHS-muIL12 and the anti-programmed death ligand 1 (PD-L1) antibody avelumab can enhance antitumor efficacy in preclinical models relative to monotherapies.Experimental Design: BALB/c mice bearing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7409a00569a1a7bee4c843188c7686
https://doi.org/10.1158/1078-0432.c.6526130.v1